Avanos Medical (AVNS) Net Margin Growth (3y) (2016 - 2026)

Avanos Medical (AVNS) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -388.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -108.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,018.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1,978.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 399.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Avanos Medical 1.16 Bn 1.10 Bn 94.20 Mn -178.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -178.00
Dec 31, 2024 7,162.00
Sep 30, 2024 1,824.00
Jun 30, 2024 -2,211.00
Mar 31, 2024 381.00
Dec 31, 2023 2,620.00
Sep 30, 2023 -742.00
Jun 30, 2023 -3,583.00
Mar 31, 2023 253.00
Dec 31, 2021 -7,208.00
Jun 30, 2021 -48.00
Mar 31, 2021 -2,479.00
Dec 31, 2020 -4,356.00
Sep 30, 2020 -741.00
Jun 30, 2020 -2,095.00
Mar 31, 2020 -1,696.00
Dec 31, 2018 5,144.00
Jun 30, 2018 1,908.00
Mar 31, 2018 1,464.00
Dec 31, 2017 1,762.00